Wittenberg Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Wittenberg Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,000	Closed	-$90K	–	83
2019 Q4	$90K	Buy	+15,000	New	+$86.8K	0.03%	75

Wittenberg Investment Management's ACHN Position: Q1 2020 in Review

Wittenberg Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 15,000 shares — an estimated $90K sold.

Wittenberg Investment Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $90K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Wittenberg Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Wittenberg Investment Management sold 15,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $90K.
Wittenberg Investment Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Wittenberg Investment Management's Achillion Pharmaceuticals position peaked at $90K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Wittenberg Investment Management's 13F filing for Q1 2020, filed 14 May 2020.